You Spoke. We Listened.
Introducing the VENTANA HER2 Dual ISH Probe Cocktail assay, part of the Roche Tissue Diagnostics Breast Cancer IHC/ISH Portfolio. Based on input from pathologists and lab professionals like you, Roche created an enhanced assay with brightfield technology for high quality in-house testing so your lab has the ability to deliver results on the first read. And that benefits everybody, from your lab team to the clinicians and patients who rely on you for results. Because the best ideas for improving assays are the ones that come from you.
Built for quality. Built for reliability. Built for you.